百时美施贵宝(BMY.US)与贝恩资本携手成立新生物制药公司以研发自身免疫性疾病疗法

智通财经
Jul 29
【百时美施贵宝(BMY.US)与贝恩资本携手成立新生物制药公司以研发自身免疫性疾病疗法】智通财经APP获悉,百时美施贵宝(BMY.US)与贝恩资本联合宣布,将成立一家新的独立生物制药公司,专注于研发自身免疫性疾病疗法。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10